South Australian Health and Medical Research Institute
The new ACRF Innovative Cancer Imaging and Therapeutics Facility enables SAHMRI researchers and their collaborators, to rapidly translate their basic biomedical research discoveries to novel cancer therapies.
This state of the art facility will be a key resource for researchers at the new SAHMRI building – a brand new institute located within a new medical and health precinct in Adelaide.
The ACRF facility houses a suite of technologies not available anywhere else in the state. It allows researchers to perform cutting-edge cell selection and imaging/profiling of cancerous behaviours within those cells.
Chief Investigators: Professor Charles Mulligan, Professor Timothy Hughes, Professor Andrew Zannettino, Professor Stan Gronthos, A/Professor Deb White, Professor Dorothy O’Keefe, MBBS MD, Professor Tanya Monro, Professor David Roder, Professor Wayne Tilley, Professor Timothy Price, Professor Peter MacKenzie.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialed for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.